"Our progress has been totally dependent on the availability of data in our rolling review and our rigorous assessment and independent advice we have received," she added. The UK regulator launched its own rolling review on Oct 30, and analysed less data than made available to the EMA. Asked about the emergency procedure used by Britain, he said EU countries had opted for a more thorough procedure to boost confidence in vaccines. Under EU rules, the Pfizer vaccine must be authorised by the EMA, but EU countries can use an emergency procedure that allows them to distribute a vaccine at home for temporary use. Britain is still subject to EU rules until it fully leaves the bloc at the end of the year.

Source: bd News24 December 02, 2020 13:41 UTC